SAN ANTONIO, April 11, 2019 /PRNewswire/ -- Fe3 Medical, the creators of a transdermal patch for the treatment of iron deficiency anemia, today announced the results from its first human study of the ...

For many people with Crohn’s disease, inflammatory bowel disease or gastric bypass operations, it can be hard to maintain sufficient levels of iron in the bloodstream. That can be harder still when ...

San Antonio-based Fe3 Medical disclosed Wednesday it has raised $11 million from investors to fund clinical trials of a transdermal patch it has developed for patients suffering from iron-deficiency ...

Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio ...

Fe3 Medical has raised an $11 million Series B round that's slated to get it through clinical testing and regulatory submissions that would be sufficient to gain CE mark and FDA approval for its ...

The state of Texas has invested $3.5 million in a San Antonio medical technology company developing a skin patch to provide iron to patients suffering from iron-deficiency anemia. The state’s latest ...